, Australia

Australian life insurers sink as slump hits sector

Recovery will be a measly 0.2% in 2021.

The adverse outlook for the Australian economy will hit the country’s life insurers as total gross written premiums (GWPs) are expected to sink 2.2% this year, according to a GlobalData report.

It will bounce back to a measly 0.2% come 2021, a far cry from the previous 5.1%. The growth rate will likely remain around the 2% mark to the end of the forecast period in 2024, meaning the industry will be 22.4% smaller in 2024 than expected prior to the pandemic.

Lower consumer demand and increased impact on investment income due to financial volatility are the key factors, said analyst Deblina Mitra.

“As of July 2020, nearly one in five policyholders of superannuation pension products reduced or stopped superannuation contributions due to the COVID-19 outbreak,” Mitra added.

In addition, the pandemic has led to a rise in cyber-attacks and scams in Australia, as working from home models increased post-lockdown.

“The frequency of attacks on government, health and education services and various industries have increased in 2020. This may be one positive for the insurance industry going forward, as high-profile examples of these attacks will generate increased demand in cyber insurance products in the country,” Mitra concluded.

 

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.